| __timestamp | Dr. Reddy's Laboratories Limited | Takeda Pharmaceutical Company Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 56369000000 | 520990000000 |
| Thursday, January 1, 2015 | 62786000000 | 535405000000 |
| Friday, January 1, 2016 | 62427000000 | 558755000000 |
| Sunday, January 1, 2017 | 62453000000 | 495921000000 |
| Monday, January 1, 2018 | 65724000000 | 659690000000 |
| Tuesday, January 1, 2019 | 70421000000 | 1089764000000 |
| Wednesday, January 1, 2020 | 80591000000 | 994308000000 |
| Friday, January 1, 2021 | 86645000000 | 1106846000000 |
| Saturday, January 1, 2022 | 100551000000 | 1244072000000 |
| Sunday, January 1, 2023 | 42907000000 | 1431505000000 |
| Monday, January 1, 2024 | 115557000000 | 1431505000000 |
Igniting the spark of knowledge
In the ever-evolving pharmaceutical industry, understanding cost dynamics is crucial. This analysis delves into the cost of revenue trends for Takeda Pharmaceutical Company Limited and Dr. Reddy's Laboratories Limited from 2014 to 2024. Over this decade, Takeda's cost of revenue surged by approximately 175%, peaking in 2023 and 2024 at around 1.43 trillion. In contrast, Dr. Reddy's Laboratories experienced a more modest increase of about 105%, with a notable dip in 2023. This divergence highlights Takeda's aggressive expansion and investment strategies, while Dr. Reddy's focuses on steady growth. The data underscores the importance of strategic financial management in maintaining competitive advantage in the global pharmaceutical market. As we look to the future, these trends offer valuable insights into the operational efficiencies and market positioning of these industry leaders.
Cost of Revenue Comparison: Vertex Pharmaceuticals Incorporated vs Takeda Pharmaceutical Company Limited
Analyzing Cost of Revenue: Takeda Pharmaceutical Company Limited and Cytokinetics, Incorporated
Cost of Revenue Trends: Takeda Pharmaceutical Company Limited vs Agios Pharmaceuticals, Inc.
Cost Insights: Breaking Down Neurocrine Biosciences, Inc. and Dr. Reddy's Laboratories Limited's Expenses
Cost of Revenue: Key Insights for Dr. Reddy's Laboratories Limited and BioMarin Pharmaceutical Inc.
Cost of Revenue Trends: Dr. Reddy's Laboratories Limited vs Sarepta Therapeutics, Inc.
Cost of Revenue Comparison: Dr. Reddy's Laboratories Limited vs Lantheus Holdings, Inc.
Comparing Cost of Revenue Efficiency: Dr. Reddy's Laboratories Limited vs Grifols, S.A.
Dr. Reddy's Laboratories Limited vs CRISPR Therapeutics AG: Efficiency in Cost of Revenue Explored
Dr. Reddy's Laboratories Limited vs Ligand Pharmaceuticals Incorporated: Efficiency in Cost of Revenue Explored
Dr. Reddy's Laboratories Limited vs Geron Corporation: Efficiency in Cost of Revenue Explored
Comparing Cost of Revenue Efficiency: Dr. Reddy's Laboratories Limited vs Galapagos NV